Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
20 December 2019 | Story Charlene Stanley | Photo Anja Aucamp
Sprouting Hope
Shadei Lepholletse, BSc Genetics and Physiology; Masabata Sebusi, BCom Accounting; and Tumelo Zondi, BCom Entrepreneurial Management; three of the directors of Sprout Africa, an agriculture and agri-processing company - the perceived potential of which has earned them each a place on the list of News24’s 100 Young Mandelas of the Future.

Enactus, 100 Young Mandelas of the Future, Sprout Africa, Masabata Sebusi, Shadei Lepholletse, Tumelo Zondi, and Farai Mzungu

Kovsie students’ innovative agri-processing venture is paying off. Two years ago, a seed of resolve was planted in four young UFS women. They entered the Enactus National Competition for entrepreneurship projects –and came stone last.

But instead of giving up, they re-grouped, re-evaluated their priorities, and came up with an innovative agri-processing community-upliftment concept that has earned each of them a place on News24’s list of 100 Young Mandelas of the Future.

“We asked ourselves what the big businesses out there were looking for when it came to community development. At that stage, we focused on arts and crafts and recycling. But we realised the need was for projects providing solutions around food insecurity, water management, and sustainable development,” explains Masabata Sebusi, final-year BCom Accounting student.

Masabata and her three partners, Shadei Lepholletse, Tumelo Zondi, and Farai Mzungu, are all studying in different fields. They pooled their diverse insights, knowledge, and perspectives. And Sprout Africa was born.

The company’s aim is to give people in rural communities training in modern farming techniques, equipping them with basic business skills and helping them to find an outlet for their produce. As part of the process, the women approached potential business partners – from local supermarkets to big commercial companies – to negotiate on behalf of the farmers.

This time, they seem to have struck the right nerve. Having won various grants while the concept as still an Enactus project, they have since registered Sprout Africa as a company. Various stakeholders have already shown interest to partner with them.

Their main advice to fellow entrepreneurs: Think outside the box, find innovative ways to solve problems, learn from the communities you serve, and collaborate with people who have different skills from you.

Except for Farai, who graduated earlier this year, all of them are in their final year of study. Next year, they won’t be job hunting like other new graduates. They’ll simply be stepping full time into their innovative enterprise.

An enterprise that promises to keep on sprouting and growing. And hopefully produce seeds of inspiration for other students to pick up.

News Archive

DNA sequencer launched at the UFS
2013-11-25

Dr Gansen Pillay, Deputy Chief Executive Officer of the National Research Foundation, explaining to the scholars what will be expected of them.

The University of the Free State (UFS) can now collect immensely valuable data on drug resistance in HIV/Aids and TB with the new DNA sequencer that was launched recently at the International workshop on HIV/AIDS and TB drug resistance at the Bloemfontein Campus.

The DNA sequencer will allow the Free State province to produce viral and bacterial genetic data to fight the local development of HIV/ Aids and TB drug resistance.

The HIV and TB epidemics have expanded very fast and South Africa now has the largest HIV and TB treatment programme in the world, with over 2 million patients on treatment. However, these successful treatment programmes are now being threatened by the appearance of drug resistance.

The Free State province has been at the forefront of fighting HIV drug resistance in South Africa and has one of the most advanced treatment programmes for the management of resistance strains in the country. In addition, researchers at the University of the Free State are leading partners in the Southern African Treatment and Resistance Network (SATuRN; www.bioafrica.net/saturn), a research network that has trained over 2 000 medical officers in the treatment of drug resistance strains.

The Department of Medical Microbiology and Virology in the Medical School at the UFS has partnered with the provincial department of health, the Medical Research Council (MRC) and the Delegation of the European Union to South Africa to fund a dedicated DNA sequencer machine that will be used to generate HIV and TB drug-resistance results. This new machine will enable cutting-edge research to take place, using the data in the province and, importantly, support patients with resistance strains to have access to advanced genotypic testing techniques.

“HIV drug resistance is a very serious problem in South Africa, and the recent advances in DNA testing technology allow clinicians in the province to access drug resistance testing, which enables them to manage patients appropriately who fail treatment, and use the results to cost-effectively extend and improve patients’ lives,” says Dr Cloete van Vuuren, Specialist in Infectious Diseases at the UFS’s Faculty of Health.

Dr Dominique Goedhals, pathologist from the Department of Medical Microbiology and Virology at the UFS, adds: “We have been looking forward to expanding our work with the clinicians and researchers, using DNA sequencing to shed light on the causes and consequences of drug resistance in urban and rural settings in the province.”

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept